The ResMed Inc. (ASX: RMD) share price is up 10% in afternoon trade today after the sleep treatment business revealed its non-GAAP operating profit grew 15% to US$182 million on revenue of US$662 million for the quarter ending March 31 2019.
Adjusted or non-GAAP earnings per share came in at US89 cents, which was ahead of the median analysts’ forecasts of US83 cents per share. The earnings ‘beat’ is in large part driving the ResMed share price higher today.
However, another factor lifting the valuation today is news that gross profit margins grew 1% over the quarter to 59% as the business revealed some decent operating leverage where profits climb faster than revenues.
Moreover, ResMed also revealed its newly-acquired enterprise facing software-as-a-service (Saa) businesses such as Brightree and Matrix Care doubled revenues over the prior corresponding quarter, although admittedly much of this was to do with the timing of the acquisitions.
Overall though it seems if ResMed can demonstrate to the market that it will get a strong return on investment from its push into SaaS its stock could run higher.
After all online enterprise SaaS is just about the hottest sector on the market right now.
Where to invest $1,000 right now
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.
*Returns as of February 15th 2021
Motley Fool contributor Tom Richardson owns shares of ResMed Inc. The Motley Fool Australia has recommended ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
- On a serendipitous day, Tom Richardson is leaving the building – December 17, 2019 11:55am
- Why Aerometrex shares have doubled their IPO price – December 16, 2019 4:32pm
- Why the National Veterinary Care share price is going nuts today – December 16, 2019 3:39pm